According to the charity, FIP, which is one of a number of chronic viral infections of cats that resemble those in people, is estimated to kill up to 1.4% of cats around the world.
The infectious agent is a mutant coronavirus (FIPV) that is notoriously difficult to control: the parent enteric coronavirus is present in virtually all catteries and shelters and is shed by 60% or more of pet cats from multi-cat households,1 and vaccines are ineffective.
Among the most promising treatments against emerging viruses in humans is 'GS-5734', one of the small-molecule antivirals targeting specific proteins involved in RNA virus replication.
In studies, it has proven effective in preventing Ebola in rhesus monkeys and inhibiting coronaviruses both in tissue culture and in mouse infection models.
It was these findings that brought it to the attention of a team of veterinary researchers in the USA, led by Professor Niels Pedersen of the University of California, Davis.
Their own initial studies involving experimental FIP showed that the less chemically complex 'GS-441524', the parent nucleoside of GS-5734, was highly effective, opening the way for a field trial in cats with naturally occurring FIP, the results of which are published in this week's JFMS2.
Thirty-one cats, ranging in age from 3–73 months, were enrolled in the study, and 26 completed the planned 12 weeks or more of treatment; the remainder died or were euthanised due to their severe disease.
For these 26 cats, the clinical response was dramatic: fever usually resolved within 12–36 h, concurrent with a marked improvement in appetite, activity levels and weight gain.
In cats with the more common effusive or ‘wet’ form of FIP, abdominal effusions rapidly disappeared, starting at around 10–14 days after commencing treatment.
Encouragingly, and somewhat unexpectedly, cats with non-effusive (‘dry’) FIP and older cats responded as well to GS-441524 treatment as did cats with effusive FIP and young cats. The safety profile of GS-441524 was likewise impressive.
Currently, 24 of the 26 cats remain healthy, with one having succumbed to FIP disease and one to unrelated heart disease. Eighteen of these cats underwent just one round of treatment; the remaining eight suffered disease relapses, but these were successfully treated with a further (in two cases, a third) round of treatment at a higher dose.
Previously the prospects for cats with FIP were bleak. In a review paper on FIP published in JFMS a decade ago, Professor Pedersen stated: "no treatment has proven effective in curing cats of FIP, in spite of the claims. Cats that develop FIP inevitably die of their disease in days, weeks or months."1
Now, as he approaches the end of his professional career, Professor Pedersen is considerably more optimistic: "FIP has been my fascination for the past 50 years and I am fortunate to have reached a final stage in my career having identified safe and effective antiviral drugs. We now know that small molecules targeting specific steps in RNA virus replication are capable of safely curing various forms of FIP."
However, he cautioned: "It must be emphasised that the field trial we report was for proof-of-concept and the results cannot be immediately translated into commercially available products.
"Unfortunately, the real hope provided by these initial trials has increased, and not decreased, the desperation of owners to seek out these new drugs on the black market. As eventful as these discoveries may be, there is still much more about FIP to discover.
"I would like to thank all of the people, organizations and owners who have assisted in my research over this half century and leave remaining questions and associated discoveries for my fellow FIP researchers."
Reference
Photo: Bubba, one of the study cats, in recovery. Courtesy Adel Gastle
According to the authors, Miniature Schnauzers positively shone in their averageness in this study, because they were not commonly affected by any specific breed-related health problems.
In other words, the illnesses suffered by Miniature Schnauzers are just the common or garden things like dental disease, obesity, anal sac impaction, vomiting and ear infection, which can affect all dogs.
The study, which the authors say was the largest ever study of the breed, analysed 3,857 Miniature Schnauzers from a population of over 450,000 dogs across the UK. Its findings were that:
The average lifespan of Miniature Schnauzers was 11.7 years, which is similar to the average of 12.0 years for dogs overall.
The average adult bodyweight of Miniature Schnauzers was 10kg. Males on average were heavier than female breeds (11kg vs 9kg).
The most common disorder affecting the breed was dental disease (affecting 17.4% Miniature Schnauzers). This is similar to that of other similarly-sized breeds such as the Cavalier King Charles Spaniel (15.2%) and Border Terrier (17.6%).
Female Miniature Schnauzers are more likely to have dental disease, obesity/overweight and heart murmur. However, males are more prone to diarrhoea and claw injury.
The most common causes of death were neoplasia (14.7%), collapse (13.3%), mass-associated disorder (10.7%) and brain disorder (10.7%).
Dr Dan O’Neill, Senior Lecturer in Companion Animal Epidemiology at the RVC and Vet Compass researcher, said: "To do their best for their dogs, owners need to know what aspects of their dog’s health are the most important to protect. Thankfully, we now have the data to identify these: owners of Miniature Schnauzers and also dogs overall should pay special attention to dental care, weight management, anal sac issues and making sure their dogs eat a healthy diet."
"Based on VetCompass Programme data, the Miniature Schnauzer is currently Britain’s most average dog from the breeds that we have studied to date. Extreme breeds such as flat-faced, long-backed or teacup-sized dogs may currently be in vogue but we need to move away from extremes and towards the healthier middle-ground."
Dr Alex Gough of Independent Vet Care and co-author added: "Although a number of diseases were identified in the current study that affect Miniature Schnauzers, the commons ones did not occur more frequently in this breed than in others studied. Many popular breeds are prone to life-threatening and distressing conditions related to their breeding. Our study suggests that the Miniature Schnauzer should be considered as a relatively healthy breed, which can help owners make a decision when acquiring a new dog."
Bill Lambert, Senior Health and Welfare Manager at the Kennel Club, said: "The Kennel Club currently recognises 221 different breeds and registering these breeds with the Kennel Club provides opportunities for data to be collected so that it can contribute to high quality and large scale research, such as this study by the Royal Veterinary College.
'It is vitally important that this type of research is carried out so that breed specific information is gathered and can be made available to owners to help ensure their dogs are kept as fit and healthy as possible.
'The Miniature Schnauzer is a popular breed in the UK so being the ‘most average dog’ in terms of health, and having no breed specific health problems, is actually a good quality and is very welcome news.”
The programme includes more than 130 hours of CPD delivered by over 100 speakers from home and abroad, with talks for all members of the practice team.
The UK speakers include Rebecca Geddes on kidney medicine and nursing; Amy Newfield on IV access techniques; Rob White on brachycephalic surgery and acute abdomen surgical techniques; Penny Watson on liver disease; Dick White on the surgical team; Butty Villiers on cytology for vets and nurses; John Chitty on several rabbits, small furries and exotics topics.
BSAVA President, Professor Ian Ramsey, said: “Following months of meticulous planning we are thrilled that the programme is now live
"The sheer range and high quality of our speakers and content, together with our new, more dynamic format takes webinar learning to a new level."
“Delegates will be able to develop their skills and knowledge on topics they see regularly in practice. To make things even easier we will be providing practical resources such as client handouts for delegates to take back to their clinics. This, coupled with many speakers sharing their own notes and practical resources means less note-taking and a quicker and easier way for delegates to share what they have learnt with their colleagues.”
There will be three keynote speakers; Jenny Campbell, a former Dragon on BBC’s Dragon’s Den, will be sharing her experiences as an entrepreneur and business leader. Two other keynote names will be announced shortly.
On the social side the focus is on bringing people together online to share light-hearted entertainment and laughter. Delegates can exercise their taste buds with some wine and whisky appreciation, throw some shapes with a virtual disco, exercise their bodies as well as their minds with yoga and unwind with some restorative meditation practices.
Ian added: “This year’s BSAVA Congress is going to be the most innovative ever and deliver like never before. There is plenty of relevant and engaging CPD for every practice professional, with all the convenience of a virtual event. If you haven’t already taken a look at the programme and registered, I urge you to do so now. With prices starting at just £99 +VAT for members it represents really great value.”
To register now visit https://www.bsavaevents.com/bsavacongress2021/en/page/home
The service will be headed by José C. Almansa Ruiz DVM (Hons) MSc (Vet) MRCVS.
José qualified from the Universidad Complutense de Madrid in 2008, before completing an honours degree in dentistry and maxillofacial surgery while working in an after-hours veterinary emergency hospital in Madrid.
In 2009, he relocated to South Africa where he undertook an internship in dentistry and maxillofacial surgery at the academic hospital of the faculty of veterinary science of the University of Pretoria. In 2011, he relocated to the UK and, in 2012, began the European Veterinary Dental College diploma.
In 2015, he returned to South Africa, working in referral hospitals, before being appointed as an extraordinary lecturer in veterinary dentistry and maxillofacial surgery at the Faculty of Veterinary Science of the University of Pretoria in January 2018.
This summer, José will sit the exams to become a European Specialist in Veterinary Dentistry.
Tim Richardson, managing director of both Southfields and Davies, said: “We look forward to welcoming José to the teams at both Southfields and Davies. He brings with him a wealth of experience and knowledge in his field and is a highly-respected clinician.
"The launch of dentistry and maxillofacial services at our multi-disciplinary referral centres is another exciting addition and we’re looking forward to accepting referrals from colleagues across the profession as we continue to lead the industry in the breadth of treatments that we can now offer.”
José said: “I’m delighted to be joining the teams at Southfields and Davies, and my plan is to establish and really grow a dentistry and maxillofacial surgery service over the coming 12 months.
“I would like to start offering reconstruction techniques for those patients undergoing mandibulectomies, while I have been hoping for some time now to begin using 3D printing as part of the planning for big surgeries.
“We will be offering a very complete and advanced veterinary dentistry service. From the maxillofacial surgery point of view, fracture repair procedures will see the introduction of non-invasive techniques for repair of maxillomandibular fractures.
“Craniofacial trauma cases will be worked up more in-depth together with anaesthesia, diagnostic imaging, ophthalmology, critical care and neurology, which will offer a truly multidisciplinary approach.”
For more information, visit www.southfields.co.uk or vetspecialists.co.uk.
The case was seen by Tim Charlesworth, head of surgery, who shared details of the case.
The dog was a seven-month-old Jack Russell Terrier which had been referred suffering from urinary incontinence and preputial pruritus.
Tim said: “We believe this is the first reported case of complete unilateral duplication of the urinary tract in a dog presenting with incontinence.
“The dog concerned was born with a duplex or 'double’ left kidney. Each section of the left kidney drained urine via separate ureters into the prostate gland.
“Its urinary bladder was also divided into separate left and right compartments, each of which then drained through separate urethras that coursed through separate penises.
“The two penises were both stuck within a prepuce designed for one which, was causing the dog’s pruritus or ‘itching’ of the penis. The incontinence was caused by the left ectopic ureters.”
Tim was faced with the challenge of devising a surgical strategy that would resolve the dog’s clinical signs. He said: “The left kidney was severely dilated and was deemed to be non-functional and so the dog underwent surgery for the removal of the affected left kidney and ureters; the two halves of the bladder were united by ablation of the septum between these two cavities; the left urethra was transected and the left penis amputated to allow the right penis to have room to fully fit within the prepuce.”
Tim added: “The dog has now made a full recovery with full resolution of his clinical signs and is currently doing very well indeed. We are very pleased to have been involved with such an unusual case and are really happy that he continues to do so well.”
The case was recently written up by one of Eastcott’s interns, Mara Sprocatti, and it has now been published by Wiley Online Library in Veterinary Surgery, highlighting it as the first known case in the history of veterinary surgery.
The pads contain ophytrium and chlorhexidine at 3%. Ophytrium is a purified natural ingredient from Ophiopogon japonicus which, Ceva says, strengthens the mechanical skin barrier1, restores the balance of protective microbial flora2 and reduces irritation, while soothing the skin1. Chlorhexidine is both antibacterial and antifungal.
Ceva says that Douxo S3 Pyo pads, which come in packs of 30, provide antibacterial and antifungal efficacy within one minute and are free from soap, parabens, sulphates, phthalates, colourants and nanoparticles.
They are available in a new, hypoallergenic ‘summertime’ fragrance which pet owners liken to coconut and vanilla.
The pads add to the Douxo S3 Pyo range, which also consists of shampoo and a mousse.
Andrew Fullerton BVSc (Hons) MRCVS, product manager for Douxo S3 at Ceva said: "The new Douxo S3 range has been well received by both veterinary professionals and their clients since its launch, who find that the products are not only effective and well tolerated, but also easy-to-use. The Douxo S3 Pyo pads will enhance this range by offering an easy-to-administer antiseptic action while hydrating and maintaining the skin’s ecosystem.”
For further information, contact cevauk@ceva.com, your local territory manager or visit https://www.douxo.com/uk/Pet-Skin-Care/douxo-s3.
References
Research conducted by the PDSA in 2017 found that 75% of dogs had received a primary vaccination course when young, which dropped to 72% in 2019. According to the BSAVA, it's the first time that vaccination rates have seen a sustained drop over a three year period since vaccinations were first introduced to the UK in the '60s.
The project, titled 'A mixed methods approach to quantifying and characterising vaccine uptake and vaccine hesitancy in UK companion animals' will combine quantitative analysis of existing data from electronic health records with qualitative approaches. It will include interviews and focus-group discussions with vets and owners to gain an in-depth understanding of patterns of uptake of vaccination in UK.
Experiences, perceptions and behaviours around uptake of vaccination and the rise of vaccine hesitancy in UK pet owners will also be investigated.
Dr Gina Pinchbeck, project leader at the University of Liverpool said: “Vaccination is a vital component of preventive healthcare and it is well acknowledged that sub-optimal vaccination uptake may be associated with re-emergence of vaccine-preventable diseases in populations.
“It is essential that we understand the reasons for vaccine hesitancy in the pet population so that we can use the best methods to promote vaccine acceptance and uptake and this will be the primary focus of the study.”
The study will include the development of a knowledge and dissemination strategy, in association with PetSavers and BSAVA. This will include a project website, publication of scientific research and other articles for both practicing veterinary surgeons and for pet-owners, press releases, conference presentations and public-engagement presentations.
BSAVA President Professor Ian Ramsey added: “This project will be of great value to the veterinary profession and continues the co-operation between BSAVA and the University of Liverpool to build on the successes of the original SAVSNET partnership.”
For information on how to apply for the PhD, contact Dr Gina Pinchbeck (ginap@liverpool.ac.uk).
The BetterwithPets Prize invites entries from entrepreneurs whose work focuses on the power of the pet human bond and whose efforts are helping to transform society. Purina runs the prize in collaboration with Ashoka, a pioneer in the field of social entrepreneurship.
StreetVet was shortlisted from 150 applicants from Europe, the Middle East and North Africa. Its Accredited Hostel Scheme offers free, accessible veterinary care for pets whose owners are experiencing homelessness and support for hostel managers and staff to adopt and implement positive pet policies.
Jade Statt, co-founder of StreetVet said: “Discovering a competition that celebrates the importance of the human animal bond felt like fate, one the StreetVet team felt compelled to enter. We are so delighted that we did! Going through this process has been really enlightening and we are beyond pleased that our project has reached the final, it is a real privilege."
The finalists will take part in an online pitch on 3rd June 2020, following which, Bernard Meunier, CEO, Nestlé Purina PetCare EMENA will announce the winners.
Mary Sharrock, External Relations Director, Purina, said: "The work StreetVet do is simply amazing and I’m delighted they’ve made the shortlist. Throughout the selection process for the BetterwithPets Prize, we found ourselves inspired by so many of the initiatives which harnessed the pet-human bond in such innovative ways and create positive changes in communities."
The conference, which was held on 23rd May, brought together over 360 veterinary professionals for online sessions which provided them with a range of wellbeing tools to improve their mental and physical wellbeing.
The organisers say that in addition to delivering wellbeing CPD, they aimed to create community and connection. Co-organiser, vet Nat Scroggie, said: "The conference app platform was chosen for delegates to feel included and network freely with one another and session leaders. With over 2400 messages on the community board and 400 photos uploaded the feedback we’ve had about how positive the experience was for delegates has gone beyond our hopes. We’ve seen new working groups forming and a genuine sense of camaraderie around current challenges."
WellVet has reopened ticket sales which give access to session recordings and the conference community app until May 2021. Tickets are £55, discounted to £15 for students and year 1 graduates, available at: https://www.wellvet.co.uk/tickets. The box office will close on 30th August 2020.
BVA’s advice comes as the four nations of the UK launch contact tracing programmes to move from blanket lockdown restrictions to a more targeted approach, in line with strategies to ease lockdown restrictions.
Although slightly different across the UK, each programme will ask those who test positive for coronavirus to identify people they have been in recent contact with and those people will be contacted and asked to self-isolate for 14 days.
Relevant contact appears to be spending more than 15 minutes within two metres of another person or being in direct face-to-face contact (less than one metre) with them. At present, the schemes are voluntary, but may become mandatory at a later stage.
Northern Ireland: Test, trace, isolate, supportEngland: NHS Test and TraceScotland: Test and ProtectWales: Test Trace Protect
Employees in self-isolation are entitled to Statutory Sick Pay for every day they are in isolation, as long as they meet the eligibility conditions. Further roll out of testing may enable people to return to work sooner that 14 days if they receive a negative test.
BVA President Daniella Dos Santos said: "The next step in the Covid-19 response is shifting to a more targeted approach, but it’s clear that this could have a very significant impact on individual veterinary practices if a member of the team tests positive. The nature of veterinary work means we are in close contact with our colleagues in order to work safely with animals.
“Many veterinary teams will be understandably anxious about the impact on their ability to staff a full rota to maintain 24/7 care. And there are significant concerns about the impact on animal health and welfare if practices are unable to provide veterinary services.
"Our advice is to continue working in fixed pairs or small teams as much as possible to reduce your contact with different individuals and continue to practise good hygiene and biosecurity.
"We continue to ask neighbouring practices to work together to support those impacted by self-isolation and ensure full geographical cover for veterinary services.
"We recognise some veterinary professionals will be worried, but we urge everyone to comply with the contact tracing programmes."
The panel is an international coalition of experts who come from different professional backgrounds but who all specialise in some form in the mental wellbeing of cats.
The purpose of the panel is to help those working and caring for cats in all the various settings to understand their behavioural, emotional and cognitive capabilities and needs in order to be able to promote their mental wellbeing and ultimately protect their welfare.
Such settings include people’s homes, in catteries, in veterinary clinics, and in homing centres and on the streets. Through the sharing of initiatives and information in a confidential space, iCatCare says this will be a collaborative effort that will advance the accepted understanding and common practices in a way that would be impossible to do individually.
CEO, Claire Bessant (pictured right) said: "By working together, gaining input from great people and enabling all those who work with cats to grow their expertise, iCatCare can deliver on its mission to create a world in which each cat’s life experience will be as good as it can be’. For more information about the Feline Wellbeing Panel, visit: https://icatcare.org/about/our-expert-panel
The 'Tea-Time Training' webinar will be led by Animalcare’s Senior Veterinary Manager, Felicity Caddick.
Tea-Time Training was launched by Animalcare in April to support veterinary surgeons and nurses keep up their CPD. The webinars are short, free, refresher-style training sessions, designed to be enjoyed over a cup of tea.
Animalcare Product Manager James Beaumont said: “A missing microchipped pet is much more likely to be reunited with its owner than an animal which has not been microchipped. National Microchipping Month is a great opportunity for practices to remind clients of the benefits of microchipping and, in doing so, to strengthen their relationships with clients – relationships which are even more important given the difficult times we’re living through.”
To register for ‘4 Essentials for Successful Microchipping’, visit https://mailchi.mp/animalcare/tea-time-training.
According to the charity, the fire broke out in an adjacent building in the early hours of the morning and caused considerable damage before it was put out by the fire brigade.
Luckily, the building was unoccupied at the time and nobody was hurt.
Structural damage was caused to the building and the charity reports that much of its office contents were damaged or destroyed by fire, smoke or water, including its servers.
However, because of coronavirus, the charity had already put systems in place to operate remotely, so it expects to continue service more or less as normal.
Probably the most noticeable part of the upgrade is the work we've done to make the site more mobile-phone friendly. But there are also a load of new features, including leaderboards so the most active contributors to the site can be rewarded, a group-based structure so that members can focus on their area of interest, more options for sharing content with colleagues and a brand new format designed especially for veterinary professionals, called the VetNurse Expert Help Forums. Mobile and desktop notifications of new content are also in the pipeline.
All of this builds on VetNurse.co.uk's existing strengths: providing the most popular job board for the veterinary nursing profession (made free of charge to support the profession during the pandemic) and the latest veterinary nursing news.
But it's the VetNurse Expert Help Forums we're most excited about, as they overcome the problems involved with discussing clinical issues on Facebook. The biggest of these is that Facebook gives everyone's opinion equivalence. In other words, it matters not whether you're the country's leading expert in something, or someone who really doesn't know what they are talking about, your post and your opinion is given the same level of prominence. That is fundamentally misleading.
Other problems inherent in Facebook are the fact that good quality replies get drowned in a sea of 'me too' responses, information is poorly curated, there is a lack of transparency because Facebook is not designed to highlight your professional qualifications, and experts get little or no recognition or reward for giving up their time and sharing their knowledge.
The VetNurse Expert Help Forums are designed to overcome all these issues. The concept is simple. Any veterinary nurse can come and ask a clinical question about any of thirteen nursing disciplines. But ONLY veterinary nurses and others who have advanced qualifications or experience can reply. When they do, you can verify their post as answering your question, which awards them points on a leaderboard and allows them to display a logo and contact details in their post (so they get recognition for their business or their employer).
What's more, both the person asking the question and the expert can claim the time spent towards their annual CPD requirement. Just press the 'Claim CPD' link at the top of the page and collect your certificate from the CPD section of your profile.
In due course, there will also be prizes for the most helpful experts and the best questions.
The system is already up and running on VetSurgeon.org, where it has proven very popular because it means members can ask questions without fear of having their question savaged, and know that the answers have come from people with advanced qualifications displayed in their profiles.
The VetNurse Expert Help Forums will be rolled out discipline-by-discipline in the coming weeks. We're currently looking for more nurses to become VetNurse Experts, so if you're interested, email: support@vetnurse.co.uk. The minimum requirements for being an expert are an advanced qualification and/or at least 10 years experience in a given field.
If you are a teacher at veterinary nursing college or a training practice, being VetNurse Expert is a great way to promote your courses or recruit new staff. Likewise if you are a nurse working in industry, it's a good way to highlight your employer's products or services. And finally, if you offer your own services, like referrals or locuming, it's a great way to promote those too.
Finally, we'll also be offering prizes for nurses who contribute to the normal discussion forums on VetNurse.co.uk. So come and get talking in the forums ... and get your name on the new leaderboard early!
Photo: VetNurse Publishing Editor Arlo Guthrie (Sorry, I couldn't think of anything else to illustrate the story with!)
One set of guidelines deals with intoxication from pyrethrins commonly found in flea control products or ant powders, whilst the other covers macrocyclic lactone poisoning which most often occurs due to accidental ingestion of large animal anthelmintic products.
Both intoxications are commonly associated with severe neurological symptoms.
Will Peel, Product Manager at TVM UK said: "Our guidelines have proved very useful to veterinary staff and we have received requests from vets to add new guidelines for antiparasiticide intoxications. Our focus is on helping veterinary staff provide the best possible care for their patients so we hope that these new guidelines will prove beneficial."
The guidelines can be downloaded free from https://www.tvm-uk.com/vet-resource-library.
The Association says that now there is so much information about nutrition available to pet owners from so many different sources, it is the responsibility of veterinary professionals to help them make the right decisions about appropriate feeding.
The BSAVA Guide to Nutrition is an independent guide comprising a series of factsheets for veterinary professionals on four different diet options, each accompanied by a factsheet for owners that can be given as part of the consultation.
The factsheets cover:
The factsheets provide information on the formulation of the various diet types and look at the advantages and disadvantages of the diet based on diet claims and available evidence. They also outline the safety measures that need to be taken into account when feeding a particular diet type and detail the considerations for feeding the diet to healthy dogs and cats, as well as those with particular diseases.
The new BSAVA Guide to Nutrition is available exclusively through the BSAVA Library (£25; £15 to BSAVA members).
The association says it had been contacted by a number of its members, exhibitors and speakers to express concerns about their health and safety if they attended this year’s event. Others said their employers were not allowing them to travel to external events until after Christmas.
The final decision to call off the event was due to the continued uncertainty facing large-scale events.
However, the BVNA says it now plans a virtual event to replace Congress, which will include first-class keynote speakers, interactive workshops, live interviews, themed virtual networking, and evening social quizzes.
The event will be free for BVNA members to take part but open to all.
BVNA President Jo Hinde said: "This is the first time that the BVNA have not been able to hold our congress and it was an exceptionally sad decision to have to make, however it is vital that we play our part in fighting the Covid-19 pandemic and put public safety first.
"However, we cannot let the occasion pass without marking it hence offering a weekend that celebrates all things vet nurse!
"Our congress has always been about more than just high quality CPD: it’s where the BVNA family get together with friends – old and new.
"We understand just how isolated and exhausted the veterinary community are feeling right now, and how this has negatively affected individual’s mental health. As such, we want to provide an online space to facilitate those catch ups, hear from inspiring speakers and most of all…have fun!
"I am very excited about the new event and hope vet nurses and the wider veterinary community can join us for what promises to be a fabulous time."
FirstVet says the funding will enable it to expand its service globally, including the United States, Germany, and France. It will also allow it to continue developing its product and introduce new features to improve the experience for pet owners and vets, such as new automation tools and integration with clinics' existing systems.
The latest round of financing takes FirstVet’s total funding to-date to €24.5M.
Founded in 2016 in Sweden, FirstVet currently has a presence in five markets: the United Kingdom, Norway, Denmark, Finland, and its native Sweden. The company says it has over 200,000 registered users and has provided consultations for over 150,000 pets since launch.
Currently, FirstVet consultations are offered free to millions of owners through partnerships with 20 insurance companies across all markets, including Bought By Many in the UK.
Co-founder David Prien said: "FirstVet is the first truly neutral stakeholder in the world to coordinate pet care. In what is a highly privatised industry, our reliable service provides value to the entire sector, and we are growing at an incredible rate."
It comes hot on the heels of the as-yet-unsubstantiated claim that remote dermatology diagnoses are as accurate as those conducted in person, and against a background of much debate in the profession about the risks and advantages of the various forms of telemedicine.
For this new study "Reliability of smartphone-based radiographic interpretation for evaluating cardiogenic pulmonary oedema in dogs", researchers from Universidade Federal do Paraná, Brazil, took thoracic radiographs from the medical records of 121 patients with cardiogenic pulmonary oedema or other differential diagnoses from three veterinary teaching hospitals.
All the images were then interpreted by two observers: a board-certified radiologist and an experienced cardiologist, both of whom were blinded to the patients’ diagnosis.
The images were reviewed both as JPEG images on a smartphone, and using a DICOM-viewing platform with an interval of four months between each viewing to reduce interpretation bias. The reviewers were asked to state only whether cardiogenic pulmonary oedema was present or absent. Diagnostic accuracy was assessed between interfaces and reviewers.
The authors say that the results of this study were consistent with previous research; a similar study found that small intestinal mechanical obstructions could be diagnosed from JPEG images of abdominal radiographs on a smartphone by radiologists.2
Lead author, Flavio Jojima said: "The diagnostic accuracy for cardiogenic pulmonary oedema in dogs was not significantly impaired when specialists used smartphones compared to a DICOM-viewing platform to interpret thoracic radiographs.
"This may provide supporting evidence for the use of smartphones for off-site expert interpretation of diagnostic radiographs, particularly in an out-of-hours clinical scenario, but not for routine interpretation of radiographs with a smartphone interface."
Nicholas Jeffery, editor of JSAP said: "These findings are reassuring. In off-site circumstances, particularly where immediate assessment and interpretation is needed, the use of smartphones could speed up the decision making process and enhance patient outcomes."
The clinic is led by Sebastien Behr MRCVS, an RCVS Specialist in Neurology. Patients will benefit from access to the referral centre's MRI scanner and its specialist imaging, anaesthesia and neurology teams.
Dr Behr said: "We are very excited to have launched this specialist clinic. Following detailed consultations with pet owners, the animals will be treated to the very highest level and bespoke care designed for each patient."
The practice is offering a fixed price package for routine diagnostic procedures.
For more information, visit www.willows.uk.net or contact the neurology team on 0121 721 7070.
Christine said: "Tests conducted by the Animal and Plant Health Agency have confirmed that the virus responsible for COVID-19 has been detected in a pet cat in England.
"This is a very rare event with infected animals detected to date only showing mild clinical signs and recovering within in a few days.
"There is no evidence to suggest that pets directly transmit the virus to humans. We will continue to monitor this situation closely and will update our guidance to pet owners should the situation change."
Yvonne Doyle, Medical Director at Public Health England, said: "This is the first case of a domestic cat testing positive for COVID-19 in the UK but should not be a cause for alarm.
"The investigation into this case suggest that the infection was spread from humans to animal, and not the other way round. At this time, there is no evidence that pets can transmit the disease to humans.
The pet cat was initially diagnosed by a vet with feline herpes virus, but the sample was also tested for SARS-CoV-2 as part of a research programme at the Centre for Virus Research at Glasgow University. Follow-up samples tested at the APHA laboratory in Weybridge confirmed the cat was also co-infected with SARS-CoV2 , the virus known to cause COVID-19 in humans.
BSAVA advice for practising vets about coronavirus is here and further information about testing is available here.
APPA is an oral, patented, fixed-dose combination of two synthetic secondary metabolites of plant origin, apocynin and paenol.
Under the terms of the agreement, AKL’s unnamed partner will fund a study in dogs with naturally occurring OA. The study will compare the efficacy and efficacy duration of APPA with the current standard of care for treating canine OA: non-steroidal anti-inflammatory drugs.
David Miles, AKLRD CEO, said: “Just like humans, millions of dogs suffer intolerable pain and disability because of OA and the current treatments just aren’t as effective or as well tolerated as they need to be. We already know from previous canine studies that APPA reduces pain and has an excellent tolerability profile but this exciting new partnership will allow us to go one stage further and assess sustainability of response.”
The randomised study will assess pain and duration of response as the primary endpoint. Secondary endpoint assessment will include adverse events, quality of life, pharmacokinetics analysis and biomarkers that may enable potential identification of factors predictive of response at treatment onset, or that correlate with response magnitude.
Two separate studies on dogs have already been carried out by researchers at the University of Vienna. The first, an 11-week cross-over study of 32 canines diagnosed with established, naturally occurring OA, showed that APPA provides significant symptom relief in clinical canine OA1.
A follow-up, five-week study of 60 dogs with OA compared APPA to the standard of care drug, meloxicam. It concluded that daily oral administration of APPA was effective as a stand-alone alternative to NSAIDs in dogs with naturally occurring OA. Significant benefits were also seen for APPA over meloxicam in orthopaedic examination as well as in lameness and function scores2.
The results will inform the pivotal clinical trial design and AKL says its working assumption is that a 26-week field study would complete the regulatory requirements for commercialisation.
If the study and future testing is successful, AKL estimates that APPA would be well placed to capture a significant share of the global canine OA market, which is estimated to be worth $3billion by 20283.
For the research, 2000 pet owners were asked whether they they had bought counterfeit pet medicines online. 31.3% said yes. They were then asked if they had reported the matter. 62.2% said they had. Finally, they were asked what the outcome of their report was. 60.9% said their purchase was confirmed as a fake, suggesting that at least one in ten pet owners - probably more - have bought fake pet medicines.
Bayer says the true number of owners affected is likely to be even higher, as a further 12% of pet owners in the survey said they believed that they may have bought fake pet medicines but had not reported it.
The research also showed that 87% of shoppers purchased pet parasite prevention products from unaccredited sites that have been known to sell counterfeit pet medicines. Indeed since April this year, the VMD has removed over 500 veterinary medicine listings from online marketplaces.
The message to clients is that chasing the lowest price for veterinary medicines can be a false economy.
Photo: Can you tell whether this product is fake or not?
Tramvetol is presented in two pack sizes of 30 and 100 tablets to assist practices with dispensing and storage as a Schedule 3 controlled drug. The meat flavoured 50mg tablets can also be divided into two equal parts to ensure accurate dosing.
Virbac says Tramvetol is suitable for both short courses and long-term treatment; 2-4mg per kg of Tramvetol can be administered every 8 hours or from 6 hours, if required, based on the intensity of the pain. In addition, Tramvetol has a wide therapeutic window and a maximum daily dose of 16mg per kg.
Commonly used in combination with other forms of analgesia, including NSAIDs1, Tramvetol is quickly absorbed and boats a rapid onset of action2. Peak plasma concentrations are achieved within 45 minutes3.
Dan Johnson, Product Manager at Virbac said: ‘Tramadol is already an important part of the analgesia toolkit for many veterinary practices. We hope that Tramvetol will prove to be a much more convenient option for practices, whilst helping to provide dogs with a better quality, pain free life’.
For more information, contact your Virbac Territory Manager.
The BVA has partnered with Closer Still Media, the impresarios behind the London Vet Show, to organise the event. They say it will cater for 1,500 veterinary professionals and provide high-value, low-cost, practical clinical and non-clinical CPD, big issue debates, and showcase key veterinary suppliers and vendors in the exhibition in a vibrant central location.
BVA President Daniella Dos Santos said: "I’m delighted to announce the launch of BVA Live. It’s an opportunity for BVA to return to hosting our own standalone conference for the first time since BVA Congress became part of the London Vet Show in 2013. The new conference will enable the veterinary community to come together, outside of London, to develop and thrive through a programme of excellent CPD, delivered by world class speakers.
"For me the most important element of BVA Live is bringing the veterinary profession together to tackle the big issues we face and providing an opportunity to engage with BVA Officers, volunteers and staff in one central venue. By hosting the conference at the NEC, Birmingham, with its excellent direct road, rail and air links it means that we can provide a greater regional offering to the veterinary profession."
It remains to be seen what impact this new conference will have on BSAVA Congress, which for many years was pretty much the only gig in town. Then, with the London Vet Show snapping at its heels, it announced it would move north from Birmingham to Manchester from 2021. Hardly will the dust have settled, than BVA and CloserStill are filling the void. At this rate, BSAVA Congress will probably have to move to the Hebrides by 2025.
It looks like there are a lot of dice being rolled here. Will more vets want to meet in Manchester than Birmingham? Will any of us be meeting in 2021 anyway, or will coronavirus continue to limit gatherings in 2021?
For more information and to register your interest in attending, visit bvalive.vetshow.com